Zanubrutinib-d5
Product Specifications
Target
BTK
Related Pathways
Angiogenesis, Tyrosine Kinase/Adaptors
Purity
>99.99%
Bioactivity
Zanubrutinib-d5 (BGB-3111-d5), a deuterium-labeled Zanubrutinib, is an orally available Bruton's tyrosine kinase inhibitor for the study of B-cell malignancies.
Smiles
O=C(N)C1=C2NCC[C@@H](C3CCN(C(C=C)=O)CC3)N2N=C1C4=CC=C(OC5=C([2H])C([2H])=C([2H])C([2H])=C5[2H])C=C4
Molecular Formula
C27H29N5O3
Molecular Weight
476.58
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC402877-100 1x 100 µL
CD45RB (B-Cell Marker) (PTPRC/2877R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
